AXS-02 (oral zoledronate)
AXS02-301
Phase 3 small_molecule active
Quick answer
AXS-02 (oral zoledronate) for Complex Regional Pain Syndrome is a Phase 3 program (small_molecule) at Axsome Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Axsome Therapeutics
- Indication
- Complex Regional Pain Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active